MetLife said it entered into a Note Purchase Agreement on June 17, 2025 and issued yen-denominated senior notes with a total principal amount of ¥87,840,000,000 in a private placement.

1. 01

   MetLife said it entered into a Note Purchase Agreement on June 17, 2025 and issued yen-denominated senior notes with a total principal amount of ¥87,840,000,000 in a private placement.

2. 02

   The company issued the notes in six series, from Series A (¥10,000,000,000, 2.14%, maturing June 17, 2032) to Series F (¥16,400,000,000, 3.62%, maturing June 17, 2055). The largest, Series E, is ¥23,600,000,000 (3.29%, maturing June 17, 2045).

3. 03

   The company said the notes bear interest on the outstanding principal at the stated annual rates from the issue date, payable semiannually on June 17 and December 17 each year, with the first payment on December 17, 2025.

4. 04

   The company said it plans to use the proceeds from the note sale to refinance the ¥25,200,000,000 0.495% senior notes due 2026 and for general corporate purposes. The notes were issued without registration under Section 4(a)(2) of the Securities Act.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.